Related Experiment Video
Updated: Dec 21, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Integration of multiple biological contexts reveals principles of synthetic lethality that affect reproducibility
Angel A Ku1, Hsien-Ming Hu1, Xin Zhao1
1Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, 94158, USA.
Abstract:
Synthetic lethal screens have the potential to identify new vulnerabilities incurred by specific cancer mutations but have been hindered by lack of agreement between studies. In the case of KRAS, we identify that published synthetic lethal screen hits significantly overlap at the pathway rather than gene level. Analysis of pathways encoded as protein networks could identify synthetic lethal candidates that are more reproducible than those previously reported. Lack of overlap likely stems from biological rather than technical limitations as most synthetic lethal phenotypes are strongly modulated by changes in cellular conditions or genetic context, the latter determined using a pairwise genetic interaction map that identifies numerous interactions that suppress synthetic lethal effects. Accounting for pathway, cellular and genetic context nominates a DNA repair dependency in KRAS-mutant cells, mediated by a network containing BRCA1. We provide evidence for why most reported synthetic lethals are not reproducible which is addressable using a multi-faceted testing framework.
Insights
Synthetic lethality screens for KRAS-mutant cancers show pathway-level overlap, not gene-level. Understanding cellular and genetic context reveals reproducible DNA repair dependencies, like BRCA1, offering a new framework for drug discovery.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Synthetic lethality screens aim to find cancer vulnerabilities but suffer from poor reproducibility.
- KRAS mutations are common in many cancers, making synthetic lethality a promising therapeutic strategy.
Purpose of the Study:
- To investigate the reasons for poor reproducibility in synthetic lethality screens for KRAS-mutant cancers.
- To identify reproducible synthetic lethal targets by considering pathway and contextual factors.
Main Methods:
- Analysis of published synthetic lethal screen data for KRAS.
- Pathway analysis using protein-interaction networks.
- Construction of a pairwise genetic interaction map.
- Investigation of cellular and genetic context modulation of synthetic lethality.
Main Results:
- Synthetic lethal hits for KRAS-mutant cancers overlap significantly at the pathway level, not the gene level.
- Biological context, including cellular conditions and genetic interactions, strongly modulates synthetic lethal phenotypes.
- A DNA repair dependency in KRAS-mutant cells, mediated by a BRCA1-containing network, was identified.
Conclusions:
- Reproducible synthetic lethal targets can be identified by analyzing pathways and considering biological context.
- A multi-faceted testing framework is needed to address the lack of reproducibility in synthetic lethality studies.
- This approach nominates DNA repair pathways as key vulnerabilities in KRAS-mutant cancers.
More Related Videos
Related Concept Videos
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
In-vitro Mutagenesis
Epistasis Analysis
Crossing Over
Pleiotropy
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

